Skip to content



July – The single molecule gene sequencing platform GenoCare 1600 has been approved for clinical application by the National Drug Administration (NMPA) of China, becoming the world’s first single molecule gene sequencer approved for clinical diagnosis by NMPA;


November – The newly developed gene sequencing platform FASTASeq 300 will be released, forming a high/medium/low flux coverage and layout of sequencing equipment from scientific research to clinical use.